<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestionSet xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionDeveloperNames>Givosiran_Initial_DISEASE_STATE_OVERVIEW_Q1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_DISEASE_STATE_OVERVIEW_Q2</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_DISEASE_STATE_OVERVIEW_Q3</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_DISEASE_STATE_OVERVIEW_Q4</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_DISEASE_STATE_OVERVIEW_Q5</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_INITIATION_CRITERIA_Q1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_INITIATION_CRITERIA_Q1_R1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_INITIATION_CRITERIA_Q2</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_GOALS_OF_THERAPY_Q1_1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_INITIATION_CRITERIA_Q2_R1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_GOALS_OF_THERAPY_Q</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_GOALS_OF_THERAPY_Q1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_COVERAGE_CRITERIA_Q1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_GOALS_OF_THERAPY_Q2_3</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_GOALS_OF_THERAPY_Q2_2</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_GOALS_OF_THERAPY_Q2_1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_GOALS_OF_THERAPY_Q2</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_GOALS_OF_THERAPY_Q1_3</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>Givosiran_Initial_GOALS_OF_THERAPY_Q1_2</assessmentQuestionDeveloperNames>
    <developerName>Givosiran_Initial_QS</developerName>
    <name>Givosiran_Initial_QS</name>
</AssessmentQuestionSet>
